These findings suggest that the presence of JAK2 mutations may complicate the clinical picture of CML, leading to misinterpretations of disease progression or treatment resistance[4]. Moreover ...

Historically, myelofibrosis treatment was palliative in nature, aimed at relieving specific symptoms. The discovery of the ...